Mitsuru Komeya

Mitsuru Komeya

Auto-generated profile, based on publicly available information

Mitsuru Komeya

Department of Urology Yokohama City University Graduate School of Medicine Yokohama Kanagawa Japan

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 August 2018 in Reproductive Medicine and Biology
Verified
Journal Article
Open access
PDF file
MKMitsuru Komeya
Mitsuru Komeya
TSTakuya Sato
Takuya Sato
TOTakehiko Ogawa
Takehiko Ogawa
Background: Spermatogenesis is one of the most complicated cellular differentiation processes in a body. Researchers struggled to find and develop a micro‐environmental condition that can support the process in vitro. Such endeavors can be traced back to a century ago and are yet continuing.Methods: Reports on in vitro spermatogenesis and related works were selected and classified into four categories based on the method used; organ culture, tubule culture, cell culture, and 3‐dimensional cell culture methods. Each report was critically reviewed from the present point of view by authors who have been working on in vitro spermatogenesis with organ culture method over a decade.Results: The organ culture method has the longest history and is the most successful method, which produced fertile mouse sperm from spermatogonial stem cells. Formulation of the medium was a key factor, most importantly serum‐derived substances. However, factors in the serum that induce and support spermatogenesis in the cultured tissue remain to be identified. In addition, the success of mouse spermatogenesis is yet to be applied to other animals. On looking into the history of cell culture method, it became clear that Sertoli cells as feeder cells play an important role. Even with Sertoli cells, however, spermatogenic development has been limited to small parts of spermatogenesis, a segmented period of meiotic prophase for instance. Recent developments of organoid or 3‐dimensional culture techniques are promising but they still need further refinements.Conclusion: The study of in vitro spermatogenesis progressed significantly over the last century. We need more work, however, to establish a culture system that can induce and maintain complete spermatogenesis of many if not all mammalian species.

1 January 2023 in The World Journal of Men's Health
Verified
Journal Article
Open access
PDF file
YYYasushi Yumura
Yasushi Yumura
TTTeppei Takeshima
Teppei Takeshima
MKMitsuru Komeya
Mitsuru Komeya
JKJurii Karibe
Jurii Karibe
SKShinnosuke Kuroda
Shinnosuke Kuroda
TSTomoki Saito
Tomoki Saito
Yumura Y, et al. World J Mens Health. 2023 Jan;41:e10. https://doi.org/10.5534/wjmh.220102

6 August 2022 in Reproductive Medicine and Biology
Verified
Journal Article
Open access
YYYasushi Yumura
Yasushi Yumura
TTTeppei Takeshima
Teppei Takeshima
MKMitsuru Komeya
Mitsuru Komeya
SKShinnosuke Kuroda
Shinnosuke Kuroda
TSTomoki Saito
Tomoki Saito
JKJurii Karibe
Jurii Karibe
Background: Newly emerging serious post‐treatment complications among young male cancer survivors involve fertility and sexual function, preventing them from pursuing a normal family life.Methods: We studied and summarized published studies that assess the relationship between cancer treatments and reduced spermatogenesis or sexual dysfunction.Main findings: Infertility often occurs because of anticancer therapies that impair spermatogenesis. While some patients postremission functionally recover fertility, others experience a decreased sperm count and azoospermia. Fertility‐preserving modalities are currently being promoted worldwide to preserve spermatogenesis following cancer therapy. Patients who can ejaculate and have sperm in their semen should cryopreserve semen. However, for patients who have never ejaculated before puberty or in whom spermatogenesis has not been established, testis biopsy is performed to collect and preserve sperm or germ cells. Fertility preservation is gaining popularity and requires continuous information dissemination to oncologists and cancer treatment professionals. Furthermore, male sexual dysfunction predominantly involves erectile dysfunction and ejaculation disorder.Conclusion: Although preventive and therapeutic methods for these disorders have been established within urology, patients and medical professionals in other fields remain uninformed of these advances. Therefore, dissemination of information regarding fertility preservation techniques should be accelerated.

4 March 2020 in International Urology and Nephrology
Verified
Journal Article
Closed access
PDF file
KUKimitsugu Usui
Kimitsugu Usui
MKMitsuru Komeya
Mitsuru Komeya
MTMasataka Taguri
Masataka Taguri
KKKoshi Kataoka
Koshi Kataoka
TATakuo Asai
Takuo Asai
JMJunichi Matsuzaki
Junichi Matsuzaki

25 September 2020 in World Journal of Urology
Verified
Journal Article
Closed access
PDF file
MKMitsuru Komeya
Mitsuru Komeya
HOHisakazu Odaka
Hisakazu Odaka
TWTakahiko Watanabe
Takahiko Watanabe
HKHirokazu Kiuchi
Hirokazu Kiuchi
TOTakehiko Ogawa
Takehiko Ogawa
JMJunichi Matsuzaki
Junichi Matsuzaki

1 April 2024 in Journal of Endourology
Verified
Journal Article
Closed access
HIHiroki Ito
Hiroki Ito
KUKoichi Uemura
Koichi Uemura
MIMaiko Ikeda
Maiko Ikeda
RJRyosuke Jikuya
Ryosuke Jikuya
TKTakuya Kondo
Takuya Kondo
KMKazuhide Makiyama
Kazuhide Makiyama
Objective: Complete endophytic renal tumors (CERTs) are the most challenging for robot-assisted partial nephrectomy (RAPN). This study aimed to determine the impact of CERT on outcomes of RAPN. Methods: All RAPN cases for localized renal tumor undertaken at Yokohama City University Hospital between 2016 and 2023 were enrolled. Tumor characteristics and surgical, functional, and oncologic outcomes of RAPN were compared between CERT and non-CERT groups. Results: Consecutive 666 patients were enrolled, and 76 (11.4%) were identified as CERT (3 points of “E” score). CERT showed smaller tumor diameters ( p < 0.001), more predominant hilar tumor ( p = 0.029), higher “N” scores ( p < 0.001) and “L” scores ( p = 0.006) than non-CERT. The CERT group showed longer warm ischemia times ( p < 0.001), more frequent positive surgical margins ( p = 0.028), and relatively lower trifecta achievement rates ( p = 0.101) than the non-CERT group. In multivariable analysis, the CERT was an independent predictor for trifecta achievement but not for pentafecta achievement. Conclusions: CERT was associated with longer warm ischemia time, positive surgical margin, and lower trifecta achievement, but not with surgical complication and pentafecta achievement in RAPN. This study suggested that CERT had limited influence on long-term renal functional preservation; however, it had strong impacts on short-term surgical outcome.